Benicar and Benicar HCT significantly reduces systolic hypertension, study
Fri, 27 May 2005 06:00 PM EST
... Data from two clinical studies presented at the American Society of Hypertension''s Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that BENICAR® (olmesartan medoxomil) and BENICAR HCT® (olmesartan medoxomil/hydrochlorothiazide) were effective in treating the difficult patient with Stage 2** hypertension, as well as the less complicated Stage 1** patient, helping both achieve nationally recognized blood pressure goals... click link for more info. ...
Related Topics
- Olmesartan
- Olmesartan and Hydrochlorothiazide
- Pulmonary Hypertension
- Intracranial Hypertension
- Hypertension
- Valsartan and Hydrochlorothiazide
- Candesartan and Hydrochlorothiazide
- Telmisartan and Hydrochlorothiazide
- Eprosartan and Hydrochlorothiazide
- Benazepril and Hydrochlorothiazide
- Telmisartan
- Candesartan
- Benazepril
- Valsartan
- Fosinopril and Hydrochlorothiazide
- Metoprolol and Hydrochlorothiazide
- Retinopathy
- Hematocrit
- Benign Intracranial Hypertension
- Radiation Studies

Not Signed In -


